Project
SOS AMI Selatogrel
Ongoing - recruitment active ยท 2022 until 2026
Maeder Micha, Vetsch Susanne, Fink Karin
Type
Clinical Studies
Range
Multicentric, KSSG as participating partner
Units
Status
Ongoing - recruitment active
Start Date
2022
End Date
2026
Financing
Industry
Study Design
prospective, multi-center, double-blind, randomized, placebo-controlled, parallel-group, Phase 3 study
Brief description/objective
Multi-center, double-blind, randomized, placebo-controlled, parallel-group study to evaluate the efficacy and safety of self-administered subcutaneous selatogrel for prevention of all-cause death and treatment of acute myocardial infarction in subjects with a recent history of acute myocardial infarction